NCT04524897

Brief Summary

To evaluate the efficacy of Intra-lesional triamcinolone injection in the management of refractory benign esophageal Stricture in children.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Dec 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 24, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2022

Completed
Last Updated

October 27, 2020

Status Verified

August 1, 2020

Enrollment Period

10 months

First QC Date

August 16, 2020

Last Update Submit

October 25, 2020

Conditions

Keywords

triamcinololerefractory esophageal stricturechildren

Outcome Measures

Primary Outcomes (1)

  • number of patients show improvement in dysphagia scale after five session of triamcinolone injection

    number of patients show improvement in dysphagia scale after five session of triamcinolone injection

    2years

Secondary Outcomes (1)

  • the number of patients who will show complete relieve of dysphagia after five sessions of triamcinolone injection

    2years

Study Arms (1)

The use of Triamcinolone Injection

OTHER

Triamcinolone acetate (40 mg/mL)

Drug: Triamcinolone Injection in treatment of refractory benign Esophageal Stricture in children

Interventions

Triamcinolone Injection in treatment of refractory benign Esophageal Stricture with endoscopic dilatation

Also known as: Triamcinolone Injection in treatment of refractory benign Esophageal Stricture with endoscopic dilatation
The use of Triamcinolone Injection

Eligibility Criteria

Age6 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All patients admitted to Assiut University Children Hospital with:
  • refractory benign esophageal stricture(inability to successfully remediate the anatomic problem to a diameter of at least 14 mm over five sessions at two-week interval)
  • inability to maintain a satisfactory luminal diameter for four weeks once the target diameter of 14 mm has been achieved

You may not qualify if:

  • Pharyngeal stenosis precluding endoscopic examination and dilatation
  • tracheo-esophageal fistula,
  • gastric cicatrization that precluded safe placement of aguidewire
  • any patient who was unfit for general anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (9)

  • Morikawa N, Honna T, Kuroda T, Watanabe K, Tanaka H, Takayasu H, Fujino A, Tanemura H, Matsukubo M. High dose intravenous methylprednisolone resolves esophageal stricture resistant to balloon dilatation with intralesional injection of dexamethasone. Pediatr Surg Int. 2008 Oct;24(10):1161-4. doi: 10.1007/s00383-008-2224-7.

    PMID: 18704454BACKGROUND
  • Contini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol. 2013 Jul 7;19(25):3918-30. doi: 10.3748/wjg.v19.i25.3918.

    PMID: 23840136BACKGROUND
  • Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014 Dec;52(10):1032-283. doi: 10.3109/15563650.2014.987397.

    PMID: 25559822BACKGROUND
  • Park KS. Evaluation and management of caustic injuries from ingestion of Acid or alkaline substances. Clin Endosc. 2014 Jul;47(4):301-7. doi: 10.5946/ce.2014.47.4.301. Epub 2014 Jul 28.

    PMID: 25133115BACKGROUND
  • Kochman ML, McClave SA, Boyce HW. The refractory and the recurrent esophageal stricture: a definition. Gastrointest Endosc. 2005 Sep;62(3):474-5. doi: 10.1016/j.gie.2005.04.050. No abstract available.

    PMID: 16111985BACKGROUND
  • Berger M, Ure B, Lacher M. Mitomycin C in the therapy of recurrent esophageal strictures: hype or hope? Eur J Pediatr Surg. 2012 Apr;22(2):109-16. doi: 10.1055/s-0032-1311695. Epub 2012 Apr 19.

    PMID: 22517516BACKGROUND
  • Ravich WJ. Endoscopic Management of Benign Esophageal Strictures. Curr Gastroenterol Rep. 2017 Aug 24;19(10):50. doi: 10.1007/s11894-017-0591-8.

    PMID: 28840483BACKGROUND
  • Nagaich N, Nijhawan S, Katiyar P, Sharma R, Rathore M. Mitomycin-C: 'a ray of hope' in refractory corrosive esophageal strictures. Dis Esophagus. 2014 Apr;27(3):203-5. doi: 10.1111/dote.12092. Epub 2013 Jun 24.

    PMID: 23796367BACKGROUND
  • Poddar U, Thapa BR. Benign esophageal strictures in infants and children: results of Savary-Gilliard bougie dilation in 107 Indian children. Gastrointest Endosc. 2001 Oct;54(4):480-4. doi: 10.1067/mge.2001.118253.

    PMID: 11577311BACKGROUND

MeSH Terms

Conditions

Esophageal Stenosis

Interventions

Triamcinolone

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

PregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Officials

  • Nagla Abou Faddan, Professor

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

ahmed osman, assistant lecturer

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assiut university children hospital, assistant lecturer ,gastroentrologyand hepatology and endoscopy unit.

Study Record Dates

First Submitted

August 16, 2020

First Posted

August 24, 2020

Study Start

December 1, 2020

Primary Completion

October 1, 2021

Study Completion

March 1, 2022

Last Updated

October 27, 2020

Record last verified: 2020-08